ACADIA Pharmaceuticals Inc. vs Analog Devices, Inc. — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.42 (market cap $5.07B), while Analog Devices, Inc. trades at $389.54 (market cap $187.67B). The key difference: Analog Devices, Inc. is far larger — about 37× ACADIA Pharmaceuticals Inc.'s market cap, and Analog Devices, Inc. pays a 1.14% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | ADI | |
|---|---|---|
Market Cap | $5.07B | $187.67B |
Sector | Health | Technology |
52-Week High | $29.41 | $445.48 |
52-Week Low | $20.06 | $225.20 |
Enterprise Value | $4.19B | $192.92B |
Dividend Yield | — | 1.14% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Analog Devices is a leading analog, mixed signal, and digital signal processing chipmaker. The firm has a significant market share lead in converter chips, which are used to translate analog signals to digital and vice versa. The company serves tens of thousands of customers, and more than half of its chip sales are made to industrial and automotive end markets. Analog Devices' chips are also incorporated into wireless infrastructure equipment.
Read more on ADI →